Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically stable live attenuated respiratory syncytial virus vaccine and its production

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

US Patent 10980872 · Granted Apr 20, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant metapneumovirus f proteins and their use2025
Recombinant metapneumovirus f proteins and their use2025
Development of dengue virus vaccine components2025
Method of vaccination with an attenuated RSV vaccine formulation2024
Method of vaccination with an attenuated RSV vaccine formulation2024
Chimeric vectors2024
Chimeric vectors2024
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated2024
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated2024
Attenuation of human respiratory syncytial virus by genome scale codon-pair deop2024
Attenuation of human respiratory syncytial virus by genome scale codon-pair deop2024
Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f p2024